Literature DB >> 17035536

Cystine/glutamate exchange modulates glutathione supply for neuroprotection from oxidative stress and cell proliferation.

Andy Y Shih1, Heidi Erb, Xiaojian Sun, Shigenobu Toda, Peter W Kalivas, Timothy H Murphy.   

Abstract

The cystine/glutamate exchanger (xCT) provides intracellular cyst(e)ine for production of glutathione, a major cellular antioxidant. Using xCT overexpression and underexpression, we present evidence that xCT-dependent glutathione production modulates both neuroprotection from oxidative stress and cell proliferation. In embryonic and adult rat brain, xCT protein was enriched at the CSF-brain barrier (i.e., meninges) and also expressed in the cortex, hippocampus, striatum, and cerebellum. To examine the neuroprotective role of xCT, various non-neuronal cell types (astrocytes, meningeal cells, and peripheral fibroblasts) were cocultured with immature cortical neurons and exposed to oxidative glutamate toxicity, a model involving glutathione depletion. Cultured meningeal cells, which naturally maintain high xCT expression, were more neuroprotective than astrocytes. Selective xCT overexpression in astrocytes was sufficient to enhance glutathione synthesis/release and confer potent glutathione-dependent neuroprotection from oxidative stress. Moreover, normally nonprotective fibroblasts could be re-engineered to be neuroprotective with ectopic xCT overexpression indicating that xCT is a key step in the pathway to glutathione synthesis. Conversely, astrocytes and meningeal cells derived from sut/sut mice (xCT loss-of-function mutants) showed greatly reduced proliferation in culture attributable to increased oxidative stress and thiol deficiency, because growth could be rescued by the thiol-donor beta-mercaptoethanol. Strikingly, sut/sut mice developed brain atrophy by early adulthood, exhibiting ventricular enlargement, thinning of the cortex, and shrinkage of the striatum. Our results indicate that xCT can provide neuroprotection by enhancing glutathione export from non-neuronal cells such as astrocytes and meningeal cells. Furthermore, xCT is critical for cell proliferation during development in vitro and possibly in vivo.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17035536      PMCID: PMC6674710          DOI: 10.1523/JNEUROSCI.3178-06.2006

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  63 in total

1.  Cloning and expression of a plasma membrane cystine/glutamate exchange transporter composed of two distinct proteins.

Authors:  H Sato; M Tamba; T Ishii; S Bannai
Journal:  J Biol Chem       Date:  1999-04-23       Impact factor: 5.157

Review 2.  Glutathione metabolism in brain metabolic interaction between astrocytes and neurons in the defense against reactive oxygen species.

Authors:  R Dringen; J M Gutterer; J Hirrlinger
Journal:  Eur J Biochem       Date:  2000-08

3.  CSF amino acids and plasma--CSF amino acid ratios in adults.

Authors:  T L Perry; S Hansen; J Kennedy
Journal:  J Neurochem       Date:  1975-03       Impact factor: 5.372

4.  Compromised glutamate transport in human glioma cells: reduction-mislocalization of sodium-dependent glutamate transporters and enhanced activity of cystine-glutamate exchange.

Authors:  Z C Ye; J D Rothstein; H Sontheimer
Journal:  J Neurosci       Date:  1999-12-15       Impact factor: 6.167

5.  Activation of microglia by secreted amyloid precursor protein evokes release of glutamate by cystine exchange and attenuates synaptic function.

Authors:  S W Barger; A S Basile
Journal:  J Neurochem       Date:  2001-02       Impact factor: 5.372

6.  Astrocytes provide cysteine to neurons by releasing glutathione.

Authors:  X F Wang; M S Cynader
Journal:  J Neurochem       Date:  2000-04       Impact factor: 5.372

7.  Characterization of cystine uptake in cultured astrocytes.

Authors:  A S Bender; W Reichelt; M D Norenberg
Journal:  Neurochem Int       Date:  2000 Aug-Sep       Impact factor: 3.921

8.  Glutathione levels in primary glial cultures: monochlorobimane provides evidence of cell type-specific distribution.

Authors:  S Chatterjee; H Noack; H Possel; G Keilhoff; G Wolf
Journal:  Glia       Date:  1999-08       Impact factor: 7.452

Review 9.  Oxidative stress-inducible proteins in macrophages.

Authors:  T Ishii; K Itoh; H Sato; S Bannai
Journal:  Free Radic Res       Date:  1999-10

10.  Visualising the activity of the cystine-glutamate antiporter in glial cells using antibodies to aminoadipic acid, a selectively transported substrate.

Authors:  D V Pow
Journal:  Glia       Date:  2001-04-01       Impact factor: 7.452

View more
  125 in total

Review 1.  The cystine/glutamate antiporter system x(c)(-) in health and disease: from molecular mechanisms to novel therapeutic opportunities.

Authors:  Jan Lewerenz; Sandra J Hewett; Ying Huang; Maria Lambros; Peter W Gout; Peter W Kalivas; Ann Massie; Ilse Smolders; Axel Methner; Mathias Pergande; Sylvia B Smith; Vadivel Ganapathy; Pamela Maher
Journal:  Antioxid Redox Signal       Date:  2012-08-03       Impact factor: 8.401

2.  The effect of monosodium glutamate on the cerebellar cortex of male albino rats and the protective role of vitamin C (histological and immunohistochemical study).

Authors:  Hala E Hashem; M D El-Din Safwat; Sami Algaidi
Journal:  J Mol Histol       Date:  2011-12-06       Impact factor: 2.611

3.  Differential dependence on cysteine from transsulfuration versus transport during T cell activation.

Authors:  Sanjay K Garg; Zhonghua Yan; Victor Vitvitsky; Ruma Banerjee
Journal:  Antioxid Redox Signal       Date:  2010-12-02       Impact factor: 8.401

Review 4.  From revolution to evolution: the glutamate hypothesis of schizophrenia and its implication for treatment.

Authors:  Bita Moghaddam; Daniel Javitt
Journal:  Neuropsychopharmacology       Date:  2011-09-28       Impact factor: 7.853

5.  Regulation of system x(c)(-)activity and expression in astrocytes by interleukin-1β: implications for hypoxic neuronal injury.

Authors:  Nicole A Jackman; Tracy F Uliasz; James A Hewett; Sandra J Hewett
Journal:  Glia       Date:  2010-11-15       Impact factor: 7.452

Review 6.  Glutamate transporters in brain ischemia: to modulate or not?

Authors:  Weronika Krzyżanowska; Bartosz Pomierny; Magłorzata Filip; Joanna Pera
Journal:  Acta Pharmacol Sin       Date:  2014-03-31       Impact factor: 6.150

7.  Adaptive basal phosphorylation of eIF2α is responsible for resistance to cellular stress-induced cell death in Pten-null hepatocytes.

Authors:  Ni Zeng; Yang Li; Lina He; Xiaoling Xu; Vivian Galicia; Chuxia Deng; Bangyan L Stiles
Journal:  Mol Cancer Res       Date:  2011-10-18       Impact factor: 5.852

8.  Nonvesicular release of glutamate by glial xCT transporters suppresses glutamate receptor clustering in vivo.

Authors:  Hrvoje Augustin; Yael Grosjean; Kaiyun Chen; Qi Sheng; David E Featherstone
Journal:  J Neurosci       Date:  2007-01-03       Impact factor: 6.167

Review 9.  Glutamate transporters in the biology of malignant gliomas.

Authors:  Stephanie M Robert; Harald Sontheimer
Journal:  Cell Mol Life Sci       Date:  2013-11-27       Impact factor: 9.261

Review 10.  The Chemical Biology of Ferroptosis in the Central Nervous System.

Authors:  Rajiv R Ratan
Journal:  Cell Chem Biol       Date:  2020-04-02       Impact factor: 8.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.